Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance (Reprint from The International Journal of Biochemistry & Cell Biology, vol 37, pg 1595-1608, 2005)

被引:95
作者
Kaneto, H [1 ]
Nakatani, Y [1 ]
Kawamori, D [1 ]
Miyatsuka, T [1 ]
Matsuoka, T [1 ]
Matsuhisa, M [1 ]
Yamasaki, Y [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan
关键词
diabetes; oxidative stress ER stress; the JNK pathway;
D O I
10.1016/j.biocel.2006.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes is the most prevalent and serious metabolic disease affecting people all over the world. Pancreatic P-cell dysfunction and insulin resistance are the hallmark of type 2 diabetes. Normal P-cells can compensate for insulin resistance by increasing insulin secretion and/or beta-cell mass, but insufficient compensation leads to the onset of glucose intolerance. Once hyperglycemia becomes apparent, beta-cell function gradually deteriorates and insulin resistance aggravates. Under diabetic conditions, oxidative stress and endoplasmic reticulum stress are induced in various tissues, leading to activation of the c-Jun N-terminal kinase pathway. The activation of c-Jun N-terminal kinase suppresses insulin biosynthesis and interferes with insulin action. Indeed, suppression of c-Jun N-terminal kinase in diabetic mice improves insulin resistance and ameliorates glucose tolerance. Thus, the c-Jun N-terminal kinase pathway plays a central role in pathogenesis of type 2 diabetes and could be a potential target for diabetes therapy. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:782 / 793
页数:12
相关论文
共 99 条
[1]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[2]   β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes [J].
Ahlgren, U ;
Jonsson, J ;
Jonsson, L ;
Simu, K ;
Edlund, H .
GENES & DEVELOPMENT, 1998, 12 (12) :1763-1768
[3]   The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells [J].
Ammendrup, A ;
Maillard, A ;
Nielsen, K ;
Andersen, NA ;
Serup, P ;
Madsen, OD ;
Mandrup-Poulsen, T ;
Bonny, C .
DIABETES, 2000, 49 (09) :1468-1476
[4]   Integration of endoplasmic reticulum signaling in health and disease [J].
Aridor, M ;
Balch, WE .
NATURE MEDICINE, 1999, 5 (07) :745-751
[5]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[6]   Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation [J].
Bollheimer, LC ;
Skelly, RH ;
Chester, MW ;
McGarry, JD ;
Rhodes, CJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1094-1101
[7]   IB1 reduces cytokine-induced apoptosis of insulin-secreting cells [J].
Bonny, C ;
Oberson, A ;
Steinmann, M ;
Schorderet, DF ;
Nicod, P ;
Waeber, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16466-16472
[8]   Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].
Bonny, C ;
Oberson, A ;
Negri, S ;
Sauser, C ;
Schorderet, DF .
DIABETES, 2001, 50 (01) :77-82
[9]   Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion [J].
Brissova, M ;
Shiota, M ;
Nicholson, WE ;
Gannon, M ;
Knobel, SM ;
Piston, DW ;
Wright, CVE ;
Powers, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11225-11232
[10]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820